Steris | STE - Ebitda

Stock Price
218.71
Daily Change
-1.23 -0.56%
Monthly
-10.13%
Yearly
-1.22%
Q2 Forecast
212.82

Steris reported $389.7M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
3M USD 1.68B 227M Sep/2025
Accuray USD -685K 900K Sep/2024
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
CONMED USD 80.36M 49.87M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Ecolab USD 1.04B 8.5M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Fortive USD 309.4M 21.4M Sep/2025
Getinge SEK 3.47B 2.13B Dec/2024
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Olympus JPY 45.72B 4.58B Dec/2025
Orthofix International USD 27.88M 2.77M Dec/2025
Owens Minor USD 90.02M 2.15M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 389.7M 22.5M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025